Diallyl disulfide
CAS No. 2179-57-9
Diallyl disulfide ( —— )
产品货号. M23985 CAS No. 2179-57-9
二烯丙基二硫化物具有抗肿瘤作用,miR-200b和miR-22可增强该作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥109 | 有现货 |
|
| 25MG | ¥164 | 有现货 |
|
| 50MG | ¥231 | 有现货 |
|
| 100MG | ¥360 | 有现货 |
|
| 500MG | ¥881 | 有现货 |
|
| 1G | ¥1305 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥130 | 有现货 |
|
生物学信息
-
产品名称Diallyl disulfide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述二烯丙基二硫化物具有抗肿瘤作用,miR-200b和miR-22可增强该作用。
-
产品描述Diallyl disulfide has antitumor effect, the effect can be enhanced by miR-200b and miR-22.
-
体外实验Cell Viability Assay Cell Line:HT-29 cells Concentration:30, 60, 120 and 240 μM Incubation Time:12, 24, 48 h Result:Suppressed HT-29 cell growth by 5.3, 23.1, 45.6 and 68.3% with 30, 60, 120 and 240 μM for 24 h, respectively.Cell Cycle Analysis Cell Line:HT-29 cells Concentration:30, 60, 120 μM Incubation Time:24 hResult:The percentage of cells in the G2/M-phase was found to be 23.6, 25.9, 39.7 and 61.0% with 30, 60, 120 and 240 μM, respectively.RT-PCR Cell Line:HT-29 cells Concentration:120 μM Incubation Time:Result:The mRNA levels of ARPC3, SPINT2, SOD1, p21 and TACSTD2 were 3.52-, 7.98-, 15.6-, 13.47- and 5.92-fold higher than those in the primary cultured cells, respectively.
-
体内实验Animal Model:Male C57BL6/J mice (6-8 weeks)Dosage:40, 80 mg/kg Administration:IP; pre-treatment 1 h before a single LPS injection (100 μg/kg)Result:Prevented LPS-induced increases in immobility time in the TST and FST in mice.
-
同义词——
-
通路Apoptosis
-
靶点IL Receptor
-
受体IL Receptor|NF-κB|NOS
-
研究领域——
-
适应症——
化学信息
-
CAS Number2179-57-9
-
分子量146.3
-
分子式C6H10S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (683.67 mM)
-
SMILESC=CCSSCC=C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression.Food Chem Toxicol. 2013 Dec;62:506-13.
产品手册
关联产品
-
Pascolizumab
Pascolizumab (SB-240683) 是一种人源化抗 IL-4 单克隆抗体。Pascolizumab 具有哮喘研究的潜力。
-
Aristololactam I
Aristololactam I 具有细胞毒性效力,通过在 caspase 3 依赖性途径中诱导细胞凋亡来介导。
-
Spesolimab
Spesolimab (BI 655130) 是一种抗 IL-36R 抗体。IL-36 在免疫系统中具有重要作用,Spesolimab 可用于掌跖脓疱病 (PPP) 的研究。Spesolimab 与先天性、Th1/Th17 和中性粒细胞途径相关的生物标志物的减少有关。
021-51111890
购物车()
sales@molnova.cn

